Certified by Founder Lodge
4BIO Capital
United Kingdom - London, England
INVESTOR
1 Disclosed Funding Rounds $132,500,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.
4BIO’s objective is to invest in, support, and grow early stage companies developing
Company | Date | Round | Raised |
---|---|---|---|
Ascend Gene & Cell Therapies | May, 10 ,2023 | Series A | $132,500,000 |
Ray Therapeutics, Inc. | May, 17 ,2023 | Series A | $100,000,000 |
Vianautis | November, 14 ,2023 | Series A | $25,000,000 |